Study Evaluating the Safety Efficacy and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II)
-
- STATUS
- Recruiting
-
- End date
- Jun 27, 2022
-
- participants needed
- 150
-
- sponsor
- Corcept Therapeutics
Summary
This Phase 2, double-blind, placebo-controlled, randomized study is to assess the safety and efficacy of miricorilant (CORT118335) in obese patients with schizophrenia treated with antipsychotic medications.
Description
This is a randomized, double-blind, placebo-controlled study that will assess the safety, efficacy, and pharmacokinetics (PK) of miricorilant in obese patients with schizophrenia who are currently taking olanzapine, risperidone, paliperidone, or quetiapine.
Patients who meet the criteria for the Study CORT118335-877 will be randomized on Day 1 to receive 600 mg miricorilant, 900 mg miricorilant, or placebo for 26 weeks.
Details
| Condition | Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG), Antipsychotic-induced Weight Gain (AIWG) |
|---|---|
| Treatment | Miricorlilant |
| Clinical Study Identifier | NCT04524403 |
| Sponsor | Corcept Therapeutics |
| Last Modified on | 27 January 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer